Metraipolis › archive › dc_3eb692637fe8

Elranatamab in relapsed/refractory multiple myeloma patients on hemodialysis: A real-world case series — Europe PMC PMID:42819898

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42819898
DOI
10.46989/001c.171328
License (as archived)
solo-consultazione
Archived
2026-10-07T20:06:04.218Z
SHA-256 of the archived text
8b169265289cef846b3d66da7c92da4793d24eb2833a52749238c6c0cba43ba2
Stable URL of this page
https://metraipolis.com/documento/dc_3eb692637fe8

How to cite

Elranatamab in relapsed/refractory multiple myeloma patients on hemodialysis: A real-world case series — Europe PMC PMID:42819898 — Europe PMC (en), https://europepmc.org/article/MED/42819898 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3eb692637fe8 (Metraipolis archive dc_3eb692637fe8, sha256 8b169265289cef846b3d66da7c92da4793d24eb2833a52749238c6c0cba43ba2)
BibTeX
@misc{dc3eb692637fe8,
  title = {Elranatamab in relapsed/refractory multiple myeloma patients on hemodialysis: A real-world case series — Europe PMC PMID:42819898},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42819898},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3eb692637fe8; sha256 8b169265289cef846b3d66da7c92da4793d24eb2833a52749238c6c0cba43ba2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42819898. Agents can read the archived copy with the MCP tool read_document.